124 related articles for article (PubMed ID: 6253213)
1. Isolation and characterization of proteins carrying the feline oncornavirus-associated cell-membrane antigen.
Snyder HW; Phillips KJ; Hardy WD; Zuckerman EE; Essex M; Sliski AH; Rhim J
Cold Spring Harb Symp Quant Biol; 1980; 44 Pt 2,():787-99. PubMed ID: 6253213
[No Abstract] [Full Text] [Related]
2. Pseudotypes of feline sarcoma virus contain an 85,000-dalton protein with feline oncornavirus-associated cell membrane antigen (FOCMA) activity.
Sherr CJ; Sen A; Todaro GJ; Sliski A; Essex M
Proc Natl Acad Sci U S A; 1978 Mar; 75(3):1505-9. PubMed ID: 206902
[TBL] [Abstract][Full Text] [Related]
3. Relationship of the feline oncornavirus associated cell membrane antigen to a feline sarcoma virus encoded polyprotein.
Snyder HW; Dutta-Choudhury M; Hardy WD
Haematol Blood Transfus; 1981; 26():488-91. PubMed ID: 6274763
[No Abstract] [Full Text] [Related]
4. Feline oncornavirus-associated cell membrane antigen: evidence for an immunologically crossreactive feline sarcoma virus-coded protein.
Stephenson JR; Khan AS; Sliski AH; Essex M
Proc Natl Acad Sci U S A; 1977 Dec; 74(12):5608-12. PubMed ID: 202959
[TBL] [Abstract][Full Text] [Related]
5. Cell-surface antigens induced by RNA tumour viruses.
Kurth R; Fenyö EM; Klein E; Essex M
Nature; 1979 May; 279(5710):197-201. PubMed ID: 220541
[TBL] [Abstract][Full Text] [Related]
6. The feline oncornavirus-associated cell membrane antigen (FOCMA) is related to, but distinguishable from, FeLV-C gp70.
Snyder HW; Singhal MC; Zuckerman EE; Jones FR; Hardy WD
Virology; 1983 Dec; 131(2):315-27. PubMed ID: 6318434
[TBL] [Abstract][Full Text] [Related]
7. Characterisation of a tumour-specific antigen on the surface of feline lymphosarcoma cells.
Snyder HW; Hardy WD; Zuckerman EE; Fleissner E
Nature; 1978 Oct; 275(5681):656-8. PubMed ID: 212681
[No Abstract] [Full Text] [Related]
8. The transformation-specific proteins of avian (Fujinami and PRC-II) and feline (Synder--Theilen and Gardner--Arnstein) sarcoma viruses are immunologically related.
Barbacid M; Breitman ML; Lauver AV; Long LK; Vogt PK
Virology; 1981 Apr; 110(2):411-9. PubMed ID: 6164154
[No Abstract] [Full Text] [Related]
9. Characterization of a feline sarcoma virus-coded antigen (FOCMA-S) by radioimmunoassay.
Sherr CJ; Todaro GJ; Sliski A; Essex M
Proc Natl Acad Sci U S A; 1978 Sep; 75(9):4489-93. PubMed ID: 212755
[TBL] [Abstract][Full Text] [Related]
10. Monoclonal antibodies: detection of transformation-related antigens.
VedBrat SS; Hammerling U; Hardy WD; Borenfreund E; Prensky W
Cold Spring Harb Symp Quant Biol; 1980; 44 Pt 1,():715-20. PubMed ID: 6253171
[No Abstract] [Full Text] [Related]
11. Feline oncornavirus-associated cell membrane antigen: expression in transformed nonproducer mink cells.
Sliski AH; Essex M; Meyer C; Todaro G
Science; 1977 Jun; 196(4296):1336-9. PubMed ID: 194310
[TBL] [Abstract][Full Text] [Related]
12. Serum antibodies against feline oncornavirus-associated cell membrane antigen in cats bearing virally induced uveal melanomas.
Niederkorn JY; Shadduck JA; Albert D; Essex M
Invest Ophthalmol Vis Sci; 1981 May; 20(5):598-605. PubMed ID: 6260702
[TBL] [Abstract][Full Text] [Related]
13. Active and passive immunization of cats with inactivated feline oncornaviruses.
Schaller JP; Hoover EA; Olsen RG
J Natl Cancer Inst; 1977 Nov; 59(5):1441-50. PubMed ID: 198563
[No Abstract] [Full Text] [Related]
14. Biochemical characterization of cells transformed via transfection by feline sarcoma virus proviral DNA.
Rosenberg ZF; Sahagan BG; Snyder HW; Worley MB; Essex M; Haseltine WA
J Virol; 1981 May; 38(2):782-8. PubMed ID: 6264144
[TBL] [Abstract][Full Text] [Related]
15. Feline oncornavirus-associated cell membrane antigen: a viral and not a cellularly coded transformation-specific antigen of cat lymphomas.
Vedbrat SS; Rasheed S; Lutz H; Gonda MA; Ruscetti S; Gardner MB; Prensky W
Virology; 1983 Jan; 124(2):445-61. PubMed ID: 6186079
[TBL] [Abstract][Full Text] [Related]
16. Protection of cats against progressive fibrosarcomas and persistent leukemia virus infection by vaccination with feline leukemia cells.
Grant CK; de Noronha F; Tusch C; Michalek MT; McLane MF
J Natl Cancer Inst; 1980 Dec; 65(6):1285-92. PubMed ID: 6253714
[TBL] [Abstract][Full Text] [Related]
17. Role of viruses in the etiology of naturally occurring feline leukemia.
Essex M; Grant CK; Cotter SM; Hardy WD
Haematol Blood Transfus; 1981; 26():483-7. PubMed ID: 6274762
[No Abstract] [Full Text] [Related]
18. Three independent isolates of feline sarcoma virus code for three distinct gag-x polyproteins.
Ruscetti SK; Turek LP; Sherr CJ
J Virol; 1980 Jul; 35(1):259-64. PubMed ID: 6251274
[TBL] [Abstract][Full Text] [Related]
19. Abrogation of resistance to feline oncornavirus disease by immunization with killed feline leukemia virus.
Olsen RG; Hoover EA; Schaller JP; Mathes LE; Wolff LH
Cancer Res; 1977 Jul; 37(7 Pt 1):2082-5. PubMed ID: 67886
[TBL] [Abstract][Full Text] [Related]
20. Monoclonal antibodies to feline sarcoma virus gag and fes gene translational products.
Veronese F; Kelloff GJ; Reynolds FH; Hill RW; Stephenson JR
J Cell Biochem; 1983; 21(1):9-18. PubMed ID: 6308016
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
